Amifloxacin

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameAmifloxacin
Drug Alias Name氨氟沙星Amifloxacin mesylateWIN-49375-3WIN-49375
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionTopoisomerase II inhibitorsTopoisomerase IV inhibitorsBacterial DNA gyrase inhibitors
TargetsTopoisomerase IITopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsUrinary Tract InfectionsShock, SepticGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsUrinary Tract InfectionsShock, SepticGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A